Freemelt Holding AB (publ)
STO:FREEM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
F
|
Freemelt Holding AB (publ)
STO:FREEM
|
SE |
|
NLS Pharmaceutics AG
NASDAQ:NLSP
|
CH |
|
M
|
Max Stock Ltd
TASE:MAXO
|
IL |
|
D
|
Dimand Societe Anonyme for The Use and Construction of Real Estate Constructions Services and Participations
ATHEX:DIMAND
|
GR |
|
N
|
NVIDIA Corp
DUS:NVD
|
US |
|
M
|
Medco Energi Internasional Tbk PT
IDX:MEDC
|
ID |
|
Billington Holdings PLC
LSE:BILN
|
UK |
|
Creative Realities Inc
NASDAQ:CREX
|
US |
Wall St Price Targets
FREEM Price Targets Summary
Freemelt Holding AB (publ)
According to Wall Street analysts, the average 1-year price target for FREEM is 1.53 SEK with a low forecast of 1.515 SEK and a high forecast of 1.575 SEK.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is FREEM's stock price target?
Price Target
1.53
SEK
According to Wall Street analysts, the average 1-year price target for FREEM is 1.53 SEK with a low forecast of 1.515 SEK and a high forecast of 1.575 SEK.
What is the Revenue forecast for Freemelt Holding AB (publ)?
Projected CAGR
66%
Over the last 3 years, the compound annual growth rate for Revenue has been 13%. The projected CAGR for the next 2 years is 66%.